opening song

Promising Results of Pegozafermin in NASH Treatment: Outperforming Resmetirom in Clinical Trials

2023-06-28 20:20:00 Pegozafermin, which is being developed by 89BIO in the development of NASH (non-alcoholic steatohepatitis), which has about 130 clinical pipelines in operation around the world, is closely chasing the leading Resmetirom. Resmetirom came one step closer to commercialization by presenting the results of phase 3 clinical trials that improved fibrosis and achieved remission … Read more

Notice of expansion of CNS sales force of Samil Pharmaceutical, which took over Sandoz products

2023-06-26 02:46:01 As of this month, the withdrawal of permission for major items of Sandoz Korea, which decided to withdraw from the domestic business, has become a reality. As Samil Pharmaceutical decides to take responsibility for the remaining central nervous system (CNS)-oriented items after withdrawal, its presence in the prescription market is expected to grow … Read more

Impeachment or Controversy? The Current Crisis in the Korean Medical Association’s Executive Branch

2023-06-16 20:30:00 Signs of impeachment of the executive branch of the current Korean Medical Association are emerging within the medical community as the current medical consultative body agrees on the agenda for the number of medical schools. This is because the executive branch is not expressing a clear position on the current situation. According to … Read more

K-Bio Overseas Market Knock Challenge Is Continuity

2023-06-13 20:30:00 In Boston, one of the world’s leading bio clusters, attempts were made for domestic bio companies to enter the overseas market. The ‘2023 Bio International Convention (Bio USA)’ held from the 5th to the 8th local time was attended by 544 domestic companies, and booth exhibitions as well as partnering were actively conducted. … Read more

Transdermal Nitroglycerin for Hot Flashes: The Truth Revealed in Latest Study

2023-06-07 02:58:15 Studies have shown that transdermal nitroglycerin does not have a significant effect on hot flashes in postmenopausal women. In the first 5 weeks, the frequency of occurrence decreased by about once a day, but when the dosing cycle was increased to 12 weeks, there was no statistically significant difference from the placebo group. … Read more

Ildong Pharmaceutical begins restructuring… Executive level ERP operation

2023-05-23 10:48:45 Ildong Holdings and Ildong Pharmaceuticals will start a business renewal. This is a view of the Ildong Pharmaceutical office building. On the 23rd, Ildong Pharmaceutical Group announced to internal members a plan for reform, including efficiency in research costs, promotion of early license out (L/O) of pipelines, item restructuring, and employee ERP. This … Read more

Emphasis on IQVIA Bio Korea’s surprise booth as a biopharmaceutical partner

2023-05-12 22:10:11 “I came out to raise IQVIA’s awareness and publicize its role as a partner at a time when Korea’s biopharmaceutical industry is growing.” IQVIA Korea, a company specializing in clinical development and data, participated in BIOKOREA 2023 for the first time this year and is actively communicating with the domestic pharmaceutical bio industry. … Read more

AstraZeneca Korea appoints executive director Lim Jae-yoon as head of the medical department

2023-05-04 02:47:52 AstraZeneca Korea Department of Medicine Jaeyoon Lim Executive Director AstraZeneca Korea announced on the 4th that it had appointed Lim Jae-yoon (Country Medical Director) to oversee the medical department. Lim Jae-yoon, Executive Director of AstraZeneca Korea Medical Department, joined AstraZeneca Korea Medical Department as Oncology therapeutic area Lead in 2019 and contributed to … Read more